Jeff Bezos is funding Flourish, a neuroscience startup valued at $2.5 billion, to study real neurons with the goal of discovering fundamental algorithmic principles that could reshape AI development. The company's approach represents a shift from large language models toward understanding the biological basis of intelligence.
Why it matters: If successful, this research could unlock more efficient AI architectures and move the industry away from pure scaling toward biologically-inspired algorithms—a potentially transformative shift in how AI is built.